Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: A 10-year follow-up study

Chinese Medical Journal

Volumn 127, Issue 8, 2014, Pages 1454-1458

  Zhou, Li Ya ^a   Lin, San Ren ^a   Ding, Shi Gang ^a   Huang, Xue Biao ^a   Jin, Zhu ^a   Cui, Rong Li ^a   Meng, Ling Mei ^a   Li, Yuan ^a   Zhang, Li ^a   Guo, Chang Ji ^a   Xue, Yan ^a   Yan, Xiu E ^a   Zhang, Jing ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Atrophic gastritis; Gastric cancer; Helicobacter pylori; Intestinal metaplasia

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE; PLACEBO; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BACTERIAL CLEARANCE; CANCER INCIDENCE; CELL AGGREGATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DYSPLASIA; FEMALE; FOLLOW UP; GASTROSCOPY; HELICOBACTER INFECTION; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; LYMPHOID CELL; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; RANDOMIZED CONTROLLED TRIAL; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH CANCER; STOMACH MUCOSA; UREA BREATH TEST; DRUG EFFECTS; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; STOMACH NEOPLASMS;

ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; STOMACH NEOPLASMS;

EID: 84898892046     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20132494     Document Type: Article

References (27)

1. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
2. IARC Working Group on the evaluation of carcinogenic risks to humans. Biological agents. Volume 100B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 2012; 100 (Pt B): 1-441.
3. Ekström AM, Held M, Hansson LE, Engstrand L, Nyrén O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001; 121: 784-791.
4. Brenner H, Arndt V, Stegmaier C, Ziegler H, Rothenbacher D. Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? Am J Epidemiol 2004; 159: 252-258.
5. Ma JL, Zhang L, Pan KF, Liu WD, Feng GS, You WC. Helicobacter pylori and the progression of gastric cancer: a 10- year cohort study (in Chinese). Natl Med J China 2005; 85: 2758-2761.
6. Kosunen TU, Pukkala E, Sarna S, Seppälä K, Aromaa A, Knekt P, et al. Gastric cancers in finnish patients after cure of helicobacter pylori infection: a cohort study. Int J Cancer 2011; 128: 433-439.
7. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-194.
8. Malfertheiner P, Megraud F, O'Morain CA, for the European Helicobacter Study Group. Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report. Gut 2012; 61: 646-664.
9. Sung JJ, Lin SR, Ching JY, Zhou LY, To KF, Wang RT, et al. Atrophy and intestinal metaplasia one year after cure of H.pylori infection: a prospective randomized study. Gastroenterology 2000; 119: 7-14.
10. Zhou LY, Sung JJ, Lin SR, Zhu J, Ding SG, Huang XB, et al. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication. Chin Med J 2003; 116: 11-14.
11. Leung WK, Lin SR, Ching JY, To KF, Ng EK, Chan FK, et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 2004; 53: 1244-1249.
12. Dixon MF, Genta RM, Yardley JH, Correa P, and the Participants in the International Workshop on the Histopathology of Gastritis, Houston 1994. Classification and grading of gastritis; the updated Sydney system. Am J Surg Pathol 1996; 20: 1161-1181.
13. Tepes B. Can gastric cancer be prevented? J Physiol Pharmacol 2009; 60 Suppl 7: 71-77.
14. Mohammadi M, Redline R, Nedrud J. Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbread and congenic mouse strains. Infect Immun 1996; 64: 238-245.
15. Fox JG, Wang TC. Inflammation, atrophy and gastric cancer. J Clin Invest 2007; 117: 60-69.
16. Tepes B, Kavcic B, Zaletel LK, Gubina M, Ihan A, Poljak M, et al. Two-to four-year histological follow-up of gastric mucosa after Helicobacter pylori eradication. J Pathol 1999; 188: 24-29.
17. Ito M, Haruma K. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther 2002; 16: 1449-1456.
18. Lu B, Chen MT, Fan YH, Liu Y, Meng LN. Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study. Word J Gastroenterol 2005; 11: 6518-6520.
19. Arkkila PE, Seppala K, Farkkila Ma, Veijola L, Sipponen P. Helicobacter pylori eradication in the healing of atrophic gastritis: one year prospective study. Scand J Gastroenterol 2006; 41: 782-790.
20. Shiotani A, Uedo N, Iishi H, Yoshiyuki Y, Ishii M, Manabe N, et al. Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication. Digestion 2008; 78: 113-119.
21. Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology 2009; 136: 1863-1873.
22. Herrera V, Parsonnet J. Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect 2009; 15: 971-976.
23. Marteau P, Chaput U. Bacteria as trigger for chronic gastrointestinal disorders. Dig Dis 2011; 29: 166-171.
24. Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer. Ann Intern Med 2009; 151: 121-128.
25. Zhou LY, Lin SR, Ding SG, Huang XB, Zhang L, Meng LM, et al. The changing trends of the incidence of gastric cancer after Helicobacter pylori eradication in Shandong area. Chin J Dig Dis 2005; 6: 114-115.
26. Kodama M, Murakami K, Okimoto T, Abe H, Sato R, Ogawa R, et al. Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer. Scand J Gastroenterol 2013; 48: 1249-1256.
27. Bae SE, Jung HY, Kang J, Park YS, Baek S, Jung JH, et al. Effect of Helicobacter pylori Eradication on metachronous recurrence after endoscopic resection of gastric neoplasm. Am J Gastroenterol 2014; 109: 60-67.